Aneuploidy

Human male karyotype

Trisomy Detection in GeneMarker

Human karyotype with bands and sub-bands

Aneuploidy is a condition in which the number of chromosomes in a cell is not an exact multiple of the haploid number for the species. This deviation from the normal chromosome number can result in a variety of genetic disorders and is a major cause of spontaneous abortion in humans. Aneuploidy occurs during cell division when the chromosomes do not separate properly between the two cells.

Causes

Aneuploidy is primarily caused by nondisjunction, a process that occurs when sister chromatids fail to separate during meiosis or when chromosomes fail to separate during mitosis. This error can happen in the formation of egg or sperm cells, leading to a zygote with an abnormal number of chromosomes.

Types

There are several types of aneuploidy, depending on the number and type of chromosomes affected. These include:

• Monosomy: The loss of a single chromosome (45 chromosomes instead of the usual 46 in humans), such as in Turner syndrome (45,X).
• Trisomy: The gain of an extra chromosome (47 chromosomes instead of 46), such as in Down syndrome (Trisomy 21), Patau syndrome (Trisomy 13), and Edwards syndrome (Trisomy 18).
• Tetrasomy and Pentasomy: The presence of two or three extra copies of a chromosome, respectively, which are rarer conditions.

Effects

The effects of aneuploidy vary widely, depending on the specific chromosomes involved and the extent of the abnormality. Some aneuploid conditions, such as Trisomy 21, are compatible with life and result in individuals with characteristic physical and intellectual disabilities. Other aneuploidies, especially those involving the sex chromosomes, may have milder effects. However, many aneuploidies, particularly those involving the autosomes, are so severe that they lead to spontaneous abortion during the early stages of pregnancy.

Diagnosis

Aneuploidy can be diagnosed through various prenatal testing methods, including:

• Amniocentesis: A test performed in the second trimester to analyze chromosome conditions in fetal cells.
• Chorionic villus sampling (CVS): A test conducted in the first trimester to examine the chromosomes in the placental tissue.
• Non-invasive prenatal testing (NIPT): A blood test that can detect trisomy conditions by analyzing fetal DNA in the mother's blood.

Management

Management of aneuploidy conditions depends on the specific diagnosis and the severity of symptoms. There is no cure for aneuploidy, but some treatments and interventions can help manage the symptoms and improve the quality of life for those affected. Early intervention programs, educational support, and medical treatments for specific symptoms are common approaches to managing conditions like Down syndrome.

Conclusion

Aneuploidy is a significant genetic abnormality that can lead to a wide range of developmental and health issues. Advances in genetic testing and prenatal care have improved the detection and understanding of these conditions, allowing for better management and support for affected individuals and their families.

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian